Argenx
ARGX
#630
Rank
ยฃ24.62 B
Marketcap
ยฃ406.20
Share price
0.76%
Change (1 day)
-3.83%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ2.36 B

According to Argenx 's latest financial reports the company has ยฃ2.36 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31ยฃ1.81 B4.97%
2021-12-31ยฃ1.72 B-3.42%
2020-12-31ยฃ1.78 B40.79%
2019-12-31ยฃ1.26 B118.99%
2018-12-31ยฃ0.57 B51.31%
2017-12-31ยฃ0.38 B341.87%
2016-12-31ยฃ86.71 M154.64%
2015-12-31ยฃ34.05 M-36.01%
2014-12-31ยฃ53.22 M98.43%
2013-12-31ยฃ26.82 M50.56%
2012-12-31ยฃ17.81 M-30.13%
2011-12-31ยฃ25.49 M181.54%
2010-12-31ยฃ9.05 M